-
Product Insights
Likelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Product Insights
Likelihood of Approval Analysis for Pulmonary Tuberculosis
Overview How likely is it that the drugs in Pulmonary Tuberculosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pulmonary Tuberculosis Overview Pulmonary tuberculosis (TB) is an infectious respiratory disease caused...
-
Product Insights
Likelihood of Approval Analysis for Mycoses
Overview How likely is it that the drugs in Mycoses will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Mycoses Overview Mycoses, also known as fungal infections, encompass a diverse group of...
-
Product Insights
Likelihood of Approval Analysis for Lipid Storage Disorders (Lipidoses)
Overview How likely is it that the drugs in Lipid Storage Disorders (Lipidoses) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lipid Storage Disorders (Lipidoses) Overview Lipid storage disorders, or lipidoses,...
-
Product Insights
Likelihood of Approval Analysis for Demyelinating Diseases
Overview How likely is it that the drugs in Demyelinating Diseases will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Demyelinating Diseases Overview Demyelinating diseases encompass conditions where the protective myelin sheath...
-
Product Insights
Likelihood of Approval Analysis for Disruptive Behavior Disorder
Overview How likely is it that the drugs in Disruptive Behavior Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Disruptive Behavior Disorder Overview Disruptive Behavior Disorders (DBD) encompass conditions like...
-
Product Insights
Likelihood of Approval Analysis for Peripheral Neuropathic Pain
Overview How likely is it that the drugs in Peripheral Neuropathic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Peripheral Neuropathic Pain Overview Peripheral neuropathic pain refers to a type...
-
Product Insights
Likelihood of Approval Analysis for Substance (Drug) Abuse
Overview How likely is it that the drugs in Substance (Drug) Abuse will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Substance (Drug) Abuse Overview Substance abuse refers to the problematic pattern...
-
Product Insights
Likelihood of Approval Analysis for Traumatic Pain
Overview How likely is it that the drugs in Traumatic Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Traumatic Pain Overview Traumatic pain arises from physical injuries or trauma to...
-
Product Insights
Likelihood of Approval Analysis for Motor Neuron Diseases
Overview How likely is it that the drugs in Motor Neuron Diseases will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Motor Neuron Diseases Overview Motor neuron diseases (MNDs) encompass a group...